Begin main content

Reports

We found 5040 result(s)

dexamethasone (Ozurdex)

Last Updated: April 19, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: dexamethasone
Indications: Diabetic macular edema

  • Brand Name: Ozurdex
  • Manufacturer: Allergan Inc.
  • Project Number: SR0535-000
  • Project Status: Active
  • Submission Type: NewIndication

Tags

Eye, Dexamethasone, Diabetic Retinopathy, Diabetes, Ozurdex; DME; diabetic macular edema; diabetic macular oedema

nitisinone (Orfadin)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nitisinone
Indications: Hereditary tyrosinemia type 1

  • Brand Name: Orfadin
  • Manufacturer: Sobi Canada Inc.
  • Project Number: SR0531-000
  • Project Status: Complete
  • Submission Type: New

Tags

Digestive System, Genetics, Pediatrics, Tyrosinemias, Digestive system, Genetics, Pediatrics, nitisinone; tyrosinemia

Apomorphine (Movapo)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson's disease

  • Brand Name: Movapo
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0527-000
  • Project Status: Complete
  • Submission Type: New

Tags

Apomorphine, Parkinson Disease, Parkinson, Movapo; apomorphine; apokyn; ApoGO; Uprima; Ixense; Parkinson disease; Parkinsonism; Parkinson's

tapentadol hydrochloride (Nucynta)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: tapentadol hydrochloride
Indications: pain, severe

  • Brand Name: Nucynta
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0563-000
  • Project Status: Received
  • Submission Type: NewIndication

Tags

Pain Management, Pain management

Characteristics of Remote and Isolated Managed Health Care Facilities: An Environmental Scan

Published on: April 18, 2018
Result type: Reports
Product Line: Environmental Scans
opens in document viewer

Context Providing all citizens in the geographically diverse country of Canada access to universal, equitable, and high-quality health care is a challenge that many health care decision-makers face.1 One strategy to provide vital health care services to Canadians living in remote areas has been the establishment of remote community health care f...

  • Project Number: ES0318

Use of Real-World Evidence in Single-Drug Assessments Environmental Scan

Published on: April 18, 2018
Result type: Reports
opens in document viewer

Context Traditionally, regulatory and health technology assessment (HTA) organizations rely on evidence derived from randomized controlled trials (RCTs) for the assessment of new drugs, given that RCTs are perceived as the gold standard to demonstrate efficacy and safety. However, patients in RCTs are highly selected and may not reflect the targ...